Sequence analysis and expression of VP3 gene of chicken anaemia virus by M. S., Hasmah et al.
J.Vet. Malaysia (2003)15 (J & 2): 47 - 51
SEQUENCE ANALYSIS AND EXPRESSION OF VP3 GENE OF
CHICKEN ANEMIA VIRUS
M.S. Hasmah, A.R. Omar, I.Aini and M. Hair-Bejo
Faculty of Veterinary Medicine, Universiti Putra Malaysia,
43400 UPM, Serdang, Selangor, Malaysia
SUMMARY
Chicken anemia virus (CAV) isolate BL-5 VP3 gene was amplified, sequenced and expressed in E. coli as a fusion
protein together with a six-histidine tag. The deduced amino acid sequence ofVP3 was identical to other CAY isolates
Cux-l, A2 and CIA-l except for a single amino acid substitution at position 12. SDS-PAGE and Western blot analysis
indicated that the expressed protein is insoluble and was found primarily from the cell lysate fraction. Expression of the
protein was detected as early as 1 h, with maximum expression (~12% of the total protein) at 6 h post induction with
IPTG. This study indicates that VP3 protein is highly expressed in insoluble form in E. coli. however, the biological
function of the protein remains to be studied.
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INTRODUCTION
Chicken anemia virus (CAV) is an important viral agent
that causes subclinical and clinical immunosuppressive
disease in chicken (McNulty, 1991). CAY is classified under
a newly recognised animal virus family, the Circoviridae
(Lukert et al., 1995). The virus is small, non-enveloped,
spherical, 18 to 23 nm in diameter, containing a circular
single-stranded DNA genome of2.3 kb (McNulty, 1991;
Noteborn et al., 1991).
The CAY genome has three partially overlapping major
open reading frames coding for proteins of 52 (VPl), 24
(VP2) and 14 (VP3) kDa (Claessens et al., 1991; Meehan
et al., 1992). VP 1 encodes for capsid protein which plays
an important role in virus spread and cell tropism (Renshaw
et al., 1996). However, both VPl and VP2 are essential in
inducing protective neutralising antibodies (Koch et al.,
1995). VP3 gene product, which is also known as apoptin,
is involved in the induction of apoptosis and is associated
with viral pathogenicity (Jeurissen et al., 1992; Noteborn
et al., 1994). In addition, apoptin also exhibits oncolytic
properties on human malignant cell lines (Danen- Van et
al., 1997). Being the smallest, non-glycosylated and
proline-rich among the three CAY proteins, the VP3 gene
has been cloned and expressed using different prokaryotic
systems by several investigators (Cunningham et al., 2001; ,
Pallister et al., 1994). In this study, we determined the
sequence and immunogenicity of VP3 of a local CAY
isolate BL-5.
MATERIALS AND METHODS
Virus
The CAY BL-5 isolate considered in this study has
been described previously by Chowdhury et al. (2002a).
The virus was propagated in MSB-l cells and viral DNA
was extracted following methods described previously by
Chowdhury et al. (2002a).
Polymerase chain reaction
VP3 gene was amplified using forward primer
(nts 481-497, 5'-GGAATTCAAATGAACGCTCTC-3')
and reverse primer (nts 841-856, 5'-
GGGATCCATCTTACAGTCTTA-3') which were
designed based on the sequence of a reference CAY isolate,
Cux-l (Noteborn et al., 1991). Polymerase chain reaction
(PCR) was carried out in a 50 III PCR reaction mixture
with the following thermal cycling profiles: an initial
incubation at 94°C, followed by 30 cycles of 94°C for 1
min, 60°C for 1.5 min, noc for 2 min, a final incubation at
noc for 10 min and cooling at 4°C. The PCR products
were run on 1% agarose gel electrophoresis and purified
by Geneclean kit (BIOI0l, USA) and cloned into TOPO
TA Cloning" system (Invitrogen, USA) following the
supplier's instructions.
Sequence analysis
Two positive colonies were selected and subjected to
sequencing using ABI PRISM® BigDye Terminator Cycle
Sequencing Ready Reaction Kit v2.0 (Perkin Elmer, USA)
in an automated DNA sequencer (ABI PRISM® 377 DNA
Sequencer) following method described by Chowdhury et
al. (2002b). Both clones were sequenced in both directions.
The sequence data were analysed using BLASTN 2.0.11
program of National Institute of Biotechnology Information
(NCB I). The isolates, GenBank Accession Numbers and
references of sequences used for sequence alignment were
as follows: SMSC-l (AF285882), 3-1 (AF390038)
(Chowdhury et al., 2003), Cux-l (M55918) (Noteborn et
al., 1991), Cloned isolate 10 (U66304) (Meehan et al.,
1997), CAU26917 (AF227982) (Brown et al., 2000), 704
(U65414) (Connor et al., 1991), A2 (AB031296)
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(Yamaguchi et al., 2001) and CIA-l (Ll4767) (Renshaw
et al., 1996). The sequences were aligned using the
ClustalW multiple alignment program under the "BioEdit"
software package based on the nucleotide and amino acid
sequences. The nucleotide sequences have been submitted
to GenBank database under the accession number
AF527037.
Expression ojVP3 protein
The VP3 gene was subcloned into pRSET A
(Invitrogen, USA), downstream and in-frame with the
N-terminal fusion peptide by using specific primers. The
forward primer (5'-GGGGATCCATGAACGCTCTCT-
CCAAGAAGATA-3') and reverse primer (5'-
GGGAATTCTTACAGTCTTATACACC TTCTT-3') were
designed with EcoRI and BamHI sites, respectively. The
PCR reaction mixture and thermal cycling profiles were
performed as described previously. The recombinant
plasmid was transformed into E. coli strain BL21(DE3)
pLysS as the host for expression. Protein expression was
induced by the addition of isopropyl-l-thio-B-D-
galactosidase (IPTG) to 1mM and the cells were incubated
at 37°C for up to 8 h. The bacterial cells were collected by
centrifugation and the cell pellets were dissolved in 1 ml
of phosphate buffer saline (PBS). The cells were sonicated
and centrifuged at 14,000 x g for 15 min. The supernatant
was removed to a fresh tube whereas the celllysates were
resuspended with the same volume of PBS as the
supernatant part. The celllysates and supernatant fractions
from each sample of induced and non-induced with IPTG
were prepared according to the method ofLaemmli (1970)
with slight modification. The samples were resuspended
in sample buffer [0.5 M Tris-HCl (pH 6.8), 10% (w/v) SDS,
1% (w/v) bromophenol blue, glycerol and 2-
mercaptoethanol] and boiled for 5 min before loading into
the stacking gel. Sample preparations were electrophoresed
in a 12.5% (w/v) discontinuous acrylamide slab gel
separated by a 4% (w/v) stacking gel. Following
electrophoresis, the gels were stained with Coomassie
Brilliant Blue or transferred onto a PVDF membrane
(Immun-Blot™, BIO-RAD) for Western blot analysis. The
membrane was incubated in 1% (w/v) blocking buffer
(KPL, USA) at room temperature for 2 h followed by
incubation with primary antibody ofanti-HisG monoclonal
antibody (mab) (Invitrogen, USA) diluted 1:5000 or mab
to VP3 (Mab51.3) (Chandratilleke et al.. 1991) diluted
1:2000 for 1 to 2 h. The membrane was then washed 3
times in the wash buffer (KPL, USA) and incubated in
secondary antibody solution of alkaline phosphatase
conjugated goat anti-mouse (KPL, USA) diluted 1:2500
for 2 h and in BCIPINBT phosphatase substrate system
(KPL, USA) for detection of the desired protein. The
concentration of the fusion protein was estimated using
Gene Snap Software of Syngene documentation system
(Syngene, UK) by dividing the intensity of the VP3 band
over the intensity of the total protein bands observed at
each line after induction with IPTG.
RESULTS
Analysis by agarose gel electrophoresis indicated a
single DNA fragment of expected size of approximately
400 bp from PCR amplified products (data not shown).
The complete open reading frame of VP3 of BL-5 is 366
bp in length which expected to encode for a protein of 121
amino acids. Nucleotide sequence comparison showed that
BL-5 showed more than 99% homology to CAY isolates
SMSC-l, 3-1, A2 and CIA-l with only one substitution.
This substitution resulted in a single amino acid substitution
from proline to glutamine at position 12 (Fig. 1). On the
other hand, BL-5 showed the lowest homology, 98% to
the Australian isolate CAU26917 with 6 substitutions (data
not shown). These substitutions resulted in 5 amino acid
substitutions (Fig. 1).
Based on the SOS-PAGE (Fig. 2) and Western blotting
(Fig. 3), the band of the expressed VP3 protein was found
between 15 to 20 kDa primarily from cell lysate samples
by 1 h post-induction and the intensity of the bands
increased significantly after 4 h post-induction (Fig. 2).
The concentration of the protein was 0.6% of the total E.
coli protein after 1 h which increased to 5% after 4 h post-
induction. The highest expression of 12% was at 6 h post-
induction. In contrast, the expression was undetectable from
the supernatant samples (Fig. 2). However, a faint band of
the expected size was observed following Western blotting
with antiHisG mab (Fig. 3,lane 2) indicating that the level
of expression in the supernatant samples was very low. A
faint band was also observed from the cell lysate samples
of the induced recombinant plasmid following Western
blotting using mab to VP3 (Fig. 3, lane 4).
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Fig. I.Alignment of deduced amino acid sequences of VP3
from different isolates of CAY. The deduced amino acid of
BL-5 was identical to other isolates, SI\ISC-I, 3-1,A2 and CIA-
1 except for a single amino acid substitution at position 12.
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Fig.2. Expression ofVP3 fusion protein from (a) cell lysate and (b) supernatant samples
Lane 1- BL21(DE3)pLysS host cells; Lane 2- non-recombinant plasmid; Lane 3- uninduced
recombinant plasmid (0 h); Lane 4- induced recombinant plasmid (1 h); Lane 5- induced
recombinant plasmid (2 h); Lane 6- induced recombinant plasmid (3 h); Lane 7- uninduced non-
recombinant plasmid; Lane 8- induced recombinant plasmid (4 h); Lane 9- induced recombinant
plasmid (5 h); Lane 10- induced recombinant plasmid (6 h); Lane 11-induced recombinant plasmid
(7 h); Lane 12- induced recombinant plasmid (8 h); Lane 1\1-Benchmark™ Prestained Protein
Ladder (Invitrogen, USA). The arrows show the bands of approximately 18 kDa that represent
the expressed VP3 fusion protein.
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Fig. 3.Western blot analysis on expressed VP3 fusion protein detected by (a) Anti-HisG (Invitrogen,
USA) and (b) monoclonal antibody against VP3 (l\1ab51.3)
Lane 1_ cell lysate sample of 4 h induced recombinant plasmid; Lane 2 - supernatant sample of
4 h induced recombinant plasmid; Lane 3 - cell lysate sample of infected I\1SBI cells; Lane 4-
cell lysate sample of 4 h induced recombinant plasmid. Lane 1\1- Benchmark™ Prestained Protein
Ladder.
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DISCUSSION
In this study, we analysed the nucleotide sequence of
VP3 ofa local CAVisolate BL-5. The size of the VP3 open
reading frame is similar to those of other CAV isolates
identified in previous studies (Brown et al., 2000;
Chowdhury et al., 2003; Noteborn et al., 1991; Pallister et
al., 1994). The results also showed that the VP3 gene was
well conserved and a very low variation was found in both
nucleotide and amino acid sequences. The low variation of
VP3 gene probably reflects its conserved role in viral
pathogenicity (Noteborn et al., 1994). However, the
unusually high amino acid substitution between BL-5 and
CAU29617 deserve further studies.
As shown in Fig. 3, the inability to detect a strong
signal despite the high expression was probably associated
with the poor presentation of the epitopes due to the
insoluble form of the protein. Alternatively, probably the
mab is specific against conformational epitope that is
missing in the protein. Another possible explanation, is to
the size of the protein, since most proteins with small
molecular mass are usually poor immunogens (Hey, et al.,
1994). In a recent study by Cunningham et al. (2001), it
has been shown that VP3 protein which was expressed as
a fusion protein with gluthathione S-transferase and a six-
histidine tag was mostly insoluble. The inability to express
the VP3 in soluble form was probably associated with the
overall amino acid sequences of the protein. Amino acid
sequence analysis using the ProtParam tool software (http:/
/www.expasy.com) predicated that VP3 protein is unstable
and may be less water soluble based on the high instability
index of 65.75, which exceeded the minimum value of a
stable protein with instability index 40. However,
Cunningham et al. (2001) indicated that a very low level
of antibody to VP3 is induced in response to CAV infection
in chickens suggesting that the protein can be developed
into a diagnostic reagent from the diagnosis of CAV.
Probably the use of mammalian expression systems such
as baculovirus, adenovirus and yeast may be able to produce
VP3 protein with diagnostic characteristics.
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ANALISIS JUJUKAN DAN EKSPRESI GEN VP3 VIRUS ANEMIA AYAM
Gen VP3 virus anemia ayam (CAV) isolat BL-5 diamplifikasi, dijujuk dan diekspres dalam E. coli sebagai protein
gabungan dengan tag histidina enam. Jujukan asid amino VP3 adalah serupa dengan isolat CAV lain, Cux-l, A2 dan
CIA-l kecuali bagi satu perubahan asid amino pada kedudukan 12. Analisis SDS-PAGE dan Sap Western menunjukan
protein yang terekspress adalah tidak larut air dan dijumpai kebanyakanya daripada bahagian lisat sel, Ekspresi protein
boleh dikesan seawall jam dengan ekspres maksima (-12% dari jumlah protein) pada 6 jam selepas diaruh dengan
IPTG. Kajian ini menunjukan VP3 boleh diekspres dengan banyak dalam E. coli walau bagaimanapun, fungsi biologi
protein tersebut perlu dikaji semula.
